Effect of Multivessel Coronary Artery Disease With or Without a Concomitant Chronic Total Occlusion on 1-Year Survival in Patients Treated With Rescue Angioplasty

被引:1
|
作者
De Felice, Francesco [1 ]
Fiorilli, Francesca [1 ]
Parma, Antonio [1 ]
Musto, Carmine [1 ]
Nazzaro, Marco Stefano [1 ]
Confessore, Pierpaolo [1 ]
Scappaticci, Massimiliano [1 ]
Violini, Roberto [1 ]
机构
[1] Cardiol Interventist Osped S Camillo Roma, I-00152 Rome, Italy
来源
JOURNAL OF INVASIVE CARDIOLOGY | 2013年 / 25卷 / 02期
关键词
rescue angioplasty; multivessel coronary artery disease; chronic total occlusion; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM MORTALITY; LEFT-VENTRICULAR FUNCTION; THROMBOLYTIC THERAPY; FIBRINOLYTIC THERAPY; REPERFUSION THERAPY; IMPACT; INTERVENTION; PREDICTORS; OUTCOMES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The effect of multivessel disease (MVD) with or without a concomitant chronic total occlusion (CTO) has never been investigated in patients treated with rescue percutaneous coronary intervention (PCI). Objectives. This study evaluates whether there is an increased rate of death at 1-year follow-up in patients undergoing rescue PCI with angiographic pattern of MVD and a concurrent CTO in comparison with single-vessel disease (SVD) and MVD without CTO. Methods. Among 551 consecutive patients undergoing rescue PCI, we compared the 1-year survival rates of 361 patients with SVD, 137 with MVD without a CTO, and 53 with MVD and a CTO. Results. The 1-year mortality rates of patients with SVD, MVD without CTO, and MVD with CTO were 5%, 13%, and 27%, respectively (P<.001). The Cox proportional hazard model identified the presence of MVD with CTO as a strong predictor of death at 1-year follow-up (hazard ratio [HR], 3.4; 95% confidence interval [CI], 1.6-7.1; P=.001), while MVD alone did not result as a predictor of outcome (HR, 1.9; 95% CI, 0.93.8; P=.064). Adjusted 1-year overall survival rates were 96%, 91.4%, and 83.4% (P=.001) in the groups with SVD, MVD without CTO, and MVD with CTO, respectively. Conclusion. Patients with MVD and concurrent CTO have higher mortality rates than those with SVD or MVD without CTO at 1-year follow-up after rescue PCI. MVD with CTO and not MVD alone is a predictor of death at 1-year follow-up. J INVASIVE CARDIOL 2013;25(2):64-68
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [31] Long-Term Outcomes of Drug-Eluting Stent Implantation in Patients with Multivessel Chronic Total Coronary Artery Occlusion
    Han, Yaling
    Zhang, Jian
    Jing, Quanming
    Wang, Shouli
    CIRCULATION, 2010, 122 (02) : E336 - E337
  • [32] Preserved Myocardial Viability in patients with Chronic Total Occlusion of a Single Coronary Artery with and without Collateral Circulation
    Li, ShuHeng
    He, Zuo Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [33] 10-YEAR SURVIVAL OF PATIENTS WITH A CHRONIC TOTAL OCCLUSION ON CORONARY ANGIOGRAPHY IS POOR PARTICULARLY IN THOSE WITHOUT EVIDENCE OF MYOCARDIAL VIABILITY
    Hoye, Angela
    Shah, Nisar
    Ismail, Hussein
    Khan, Fayaz
    Ahmed, Daniyal
    Ungvari, Tamas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1630 - E1630
  • [34] Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease
    Baber, Usman
    Farkouh, Michael E.
    Arbel, Yaron
    Muntner, Paul
    Dangas, George
    Mack, Michael J.
    Hamza, Taye H.
    Mehran, Roxana
    Fuster, Valentin
    EUROPEAN HEART JOURNAL, 2016, 37 (46) : 3440 - 3447
  • [35] The presence of a chronic total occlusion in patients with stelevation myocardial infarction is responsible for the increased mortality related with multivessel coronary disease
    Baptista, Sergio B.
    Abreu, Pedro F.
    Magno, Pedro
    Loureiro, Jose R.
    Monteiro, Celia
    Leal, Paulo
    Nedio, Maura
    Gil, Victor
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 99L - 100L
  • [36] Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization
    Kim, Bum Sung
    Yang, Jeong Hoon
    Jang, Woo Jin
    Song, Young Bin
    Hahn, Joo-Yong
    Choi, Jin-Ho
    Choi, Ki Hong
    Kim, Sung-Hea
    Chun, Woo Jung
    Gwon, Hyeon-Cheol
    Choi, Seung-Hyuk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (18)
  • [37] Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes
    Sanguineti, Francesca
    Garot, Philippe
    O'Connor, Stephen
    Watanabc, Yusuke
    Spaziano, Marco
    Lcfcvrc, Thicrry
    Hovassc, Thomas
    Benamer, Hakim
    Unterseeh, Thierry
    Chevalier, Bernard
    Morice, Marie-Claude
    Louvard, Yves
    EUROINTERVENTION, 2017, 12 (15) : 1889 - 1897
  • [38] Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
    Choy-Shan, Alana
    Zinn, Andrew
    Shah, Binita
    Danoff, Ann
    Donnino, Robert
    Schwartzbard, Arthur Z.
    Lorin, Jeffrey D.
    Grossi, Eugene
    Sedlis, Steven P.
    CORONARY ARTERY DISEASE, 2012, 23 (05) : 354 - 358
  • [39] Association of serum mimecan with angiographic coronary collateralization in patients with stable coronary artery disease and chronic total occlusion
    Shen, Ying
    Ding, Feng Hua
    Zhang, Rui Yan
    Zhang, Qi
    Lu, Lin
    Shen, Wei Feng
    ATHEROSCLEROSIS, 2016, 252 : 75 - 81
  • [40] Serum mimecan reflects angiographic coronary collateralization in patients with stable coronary artery disease and chronic total occlusion
    Shen, Y.
    Ding, F. H.
    Zhang, R. Y.
    Zhang, Q.
    Lu, L.
    Shen, W. F.
    EUROPEAN HEART JOURNAL, 2016, 37 : 186 - 186